Cystic fibrosis (CF) is caused by abnormal function of the CF transmembrane conductance regulator (CFTR) gene. CF is highly variable with some individuals succumbing to the disease in their first decade while others live into their fourth and fifth decades. Patients also differ in the involvement of organ systems and in complications. Some of the variation in CF phenotype can be attributed to the nature of the defect in the CFTR gene. The CFTR genotype primarily determines the degree of pancreatic exocrine dysfunction and correlates with a degree of abnormality in the sweat chloride concentration and malformation of the male reproductive tract. However, factors independent of CFTR are responsible for variation in lung disease, the primary cause of morbidity and mortality in CF. Over the past few years, modifier genes have been identified that influence lung disease severity in CF patients. Non-genetic factors such as socioeconomic status and exposure to passive smoking also affect pulmonary outcome. A more complete understanding of the causes of variation among CF patients is emerging, facilitating the development of new prognostic measures as well as novel therapies.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.